These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 17613921)
1. Risk of upper gastrointestinal events with the use of various NSAIDs: a case-control study in a general population. Helin-Salmivaara A; Saarelainen S; Grönroos JM; Vesalainen R; Klaukka T; Huupponen R Scand J Gastroenterol; 2007 Aug; 42(8):923-32. PubMed ID: 17613921 [TBL] [Abstract][Full Text] [Related]
2. NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland. Helin-Salmivaara A; Virtanen A; Vesalainen R; Grönroos JM; Klaukka T; Idänpään-Heikkilä JE; Huupponen R Eur Heart J; 2006 Jul; 27(14):1657-63. PubMed ID: 16731535 [TBL] [Abstract][Full Text] [Related]
3. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors. Battistella M; Mamdami MM; Juurlink DN; Rabeneck L; Laupacis A Arch Intern Med; 2005 Jan; 165(2):189-92. PubMed ID: 15668365 [TBL] [Abstract][Full Text] [Related]
4. COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study. Nørgård B; Pedersen L; Johnsen SP; Tarone RE; McLaughlin JK; Friis S; Sørensen HT Aliment Pharmacol Ther; 2004 Apr; 19(7):817-25. PubMed ID: 15043523 [TBL] [Abstract][Full Text] [Related]
5. The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs. van der Linden MW; van der Bij S; Welsing P; Kuipers EJ; Herings RM Ann Rheum Dis; 2009 May; 68(5):668-73. PubMed ID: 18495734 [TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase-2 inhibitors in patients on warfarin. Cheetham TC; Levy G; Niu F; Bixler F Ann Pharmacother; 2009 Nov; 43(11):1765-73. PubMed ID: 19809010 [TBL] [Abstract][Full Text] [Related]
7. Risk of upper gastrointestinal bleeding with oral bisphosphonates and non steroidal anti-inflammatory drugs: a case-control study. Etminan M; Lévesque L; Fitzgerald JM; Brophy JM Aliment Pharmacol Ther; 2009 Jun; 29(11):1188-92. PubMed ID: 19298582 [TBL] [Abstract][Full Text] [Related]
8. GI risk factors and use of GI protective agents among patients receiving nonsteroidal antiinflammatory drugs. Harris CL; Raisch DW; Abhyankar U; Marfatia S; Campbell HM; Sather MR Ann Pharmacother; 2006 Nov; 40(11):1924-31. PubMed ID: 17047140 [TBL] [Abstract][Full Text] [Related]
9. Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study. Rahme E; Bardou M; Dasgupta K; Toubouti Y; Ghosn J; Barkun AN Rheumatology (Oxford); 2007 Feb; 46(2):265-72. PubMed ID: 16844699 [TBL] [Abstract][Full Text] [Related]
10. Risk of serious upper gastrointestinal events with concurrent use of NSAIDs and SSRIs: a case-control study in the general population. Helin-Salmivaara A; Huttunen T; Grönroos JM; Klaukka T; Huupponen R Eur J Clin Pharmacol; 2007 Apr; 63(4):403-8. PubMed ID: 17347805 [TBL] [Abstract][Full Text] [Related]
12. Non-steroidal anti-inflammatory drugs use and risk of upper gastrointestinal adverse events in cirrhotic patients. Lee YC; Chang CH; Lin JW; Chen HC; Lin MS; Lai MS Liver Int; 2012 May; 32(5):859-66. PubMed ID: 22226322 [TBL] [Abstract][Full Text] [Related]
13. Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study. Schmidt M; Christiansen CF; Mehnert F; Rothman KJ; Sørensen HT BMJ; 2011 Jul; 343():d3450. PubMed ID: 21727167 [TBL] [Abstract][Full Text] [Related]
14. Non-steroidal anti-inflammatory drugs and risk of lower gastrointestinal adverse events: a nationwide study in Taiwan. Chang CH; Lin JW; Chen HC; Kuo CW; Shau WY; Lai MS Gut; 2011 Oct; 60(10):1372-8. PubMed ID: 21415083 [TBL] [Abstract][Full Text] [Related]
15. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors. van der Linden MW; Gaugris S; Kuipers EJ; van Herk-Sukel MP; van den Bemt BJ; Sen SS; Herings RM Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):880-90. PubMed ID: 19593747 [TBL] [Abstract][Full Text] [Related]
16. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs. Targownik LE; Metge CJ; Leung S; Chateau DG Gastroenterology; 2008 Apr; 134(4):937-44. PubMed ID: 18294634 [TBL] [Abstract][Full Text] [Related]
18. Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada. Rahme E; Barkun A; Nedjar H; Gaugris S; Watson D Am J Gastroenterol; 2008 Apr; 103(4):872-82. PubMed ID: 18371130 [TBL] [Abstract][Full Text] [Related]
19. Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events. Thompson PW; Tee L; McBride J; Quincey D; Strat Liddiard G Rheumatology (Oxford); 2005 Oct; 44(10):1308-10. PubMed ID: 15972345 [TBL] [Abstract][Full Text] [Related]
20. Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms. Thomas J; Straus WL; Bloom BS Am J Gastroenterol; 2002 Sep; 97(9):2215-9. PubMed ID: 12358235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]